Trademark Overview
On Tuesday, July 8, 2025, a trademark application was filed for ZOLAMIR with the United States Patent and Trademark Office. The USPTO has given the ZOLAMIR trademark a serial number of 99273717. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 8, 2025. This trademark is owned by Newcastle Bioscience, LLC. The ZOLAMIR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations used to treat one or more of the following: infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, psychiatric conditions, sleep disorders, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive diseases, and respiratory conditions